THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to any aspect of the proposals referred to in this document or as to.
The chief executive of contract research company Fusion Antibodies plc has said it’s looking forward to “better times ahead” after its losses doubled to £2.6m.